Can We Simplify Liposome Manufacturing Using a Complex DoE Approach?
Pharmaceutics · 01.09.2024 · 16 (9) · 1159
DOI: 10.3390/pharmaceutics16091159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 01.09.2024. Verfasst von Sarah Lindsay und 7 weiteren Autor:innen. Beteiligte Einrichtung: Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VLAIO (Flemish government funding agency, ‘Flanders Innovation and Entrepreneurship’).
Abstract (Originalsprache)
Microfluidic liposome production presents a streamlined pathway for expediting the translation of liposomal formulations from the laboratory setting to clinical applications. Using this production method, resultant liposome characteristics can be tuned through the control of both the formulation parameters (including the lipids and solvents used) and production parameters (including the production speed and mixing ratio). Therefore, the aim of this study was to investigate the relationship between not only total flow rate (TFR), the fraction of the aqueous flow rate over the organic flow rate (flow rate ratio (FRR)), and the lipid concentration, but also the solvent selection, aqueous buffer, and production temperature. To achieve this, we used temperature, applying a design of experiment (DoE) combined with machine learning. This study demonstrated that liposome size and polydispersity were influenced by manipulation of not only the total flow rate and flow rate ratio but also through the lipids, lipid concentration, and solvent selection, such that liposome attributes can be in-process controlled, and all factors should be considered within a manufacturing process as impacting on liposome critical quality attributes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.
- Global Development, Janssen Pharmaceutica NV, a Johnson & Johnson Company, Turnhoutseweg 30, 2340 Beerse, Belgium.
- Therapeutics Development and Supply, Janssen Pharmaceutica NV, a Johnson & Johnson Company, Turnhoutseweg 30, 2340 Beerse, Belgium.
- Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark.
ORCID-Profile: René Holm, Yvonne Perrie
Förderung
- VLAIO (Flemish government funding agency, ‘Flanders Innovation and Entrepreneurship’)
Zitieren
APA
Lindsay, S., Tumolva, O., Khamiakova, T., Coppenolle, H., Kovarik, M., Shah, S., Holm, R., & Perrie, Y. (2024). Can We Simplify Liposome Manufacturing Using a Complex DoE Approach?. Pharmaceutics, 16(9), 1159. https://doi.org/10.3390/pharmaceutics16091159
Vancouver
Lindsay S, Tumolva O, Khamiakova T, Coppenolle H, Kovarik M, Shah S, et al. Can We Simplify Liposome Manufacturing Using a Complex DoE Approach?. Pharmaceutics. 2024;16(9):1159. doi:10.3390/pharmaceutics16091159
BibTeX
@article{Lindsay2024,
author = {Lindsay, Sarah and Tumolva, Olympia and Khamiakova, Tatsiana and Coppenolle, Hans and Kovarik, Martin and Shah, Sanket and Holm, René and Perrie, Yvonne},
title = {Can We Simplify Liposome Manufacturing Using a Complex DoE Approach?},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {9},
pages = {1159},
doi = {10.3390/pharmaceutics16091159}
}
EUVIMED